REG - Directa Plus PLC - Update on Further Funding

Directa PlusAnnouncement

13/04/2026 07:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260413:nRSM1595Aa&default-theme=true

RNS Number : 1595A  Directa Plus PLC  13 April 2026

The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulations (EU) No.
596/2014 as it forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the
Company's obligations under Article 17 of MAR. Upon the publication of this
announcement, this inside information is now considered to be in the public
domain.

13 April 2026

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

Update on Funding

Notice to appoint an Administrator over a subsidiary

 

As stated in the announcement of 30 March 2026, Directa Plus  is operating
under increasing financial strain due to the need to secure additional funding
and that if no additional funding is secured, it is highly likely that this
will result in the Company and the Group not being a going concern and the
Directors having to take steps to place the Company into administration.

 

The board of Directa Plus SpA ("Directa SpA") the main Italian subsidiary, has
now informed the Company that, in light of the financial situation of that
company,  the chairman of the board of the Italian statutory auditors¹ has
indicated that they would request that Directa SpA enter into the negotiated
settlement procedure for resolving corporate distress, as provided for in
Articles 12 et seq. of Legislative Decree No. 14/2019 (the Italian Code of
Business Crisis and Insolvency), unless the board of directors of the Directa
SpA were to decide upon an alternative course, including voluntary
liquidation. As a voluntary liquidation would offer a more orderly and
flexible process, the Board of Directa Plus is reporting that Directa SpA will
continue to operate with the current two Directors, Giulio Cesareo and
Gianluigi Contin, until liquidation.

This liquidation process is subject to certification by an Italian notary
which is anticipated to be completed in late April, and the directors of
Directa SpA continue in office until that time.

In light of these developments' clarification has been sought from the
institutional investor, as to whether the up to £2.5m funding facility
announced on 30 March 2026, is capable of being progressed. The Board now
intends to immediately engage corporate restructuring advisers to protect
stakeholder's interests.

The Board is continuing to progress both the potential sale of non-strategic
land held by its Romanian environmental remediation subsidiary Setcar SA, as
well as evaluating options for the sale of Setcar.

Due to the ongoing financial uncertainty regarding the Group, its limited
working capital and the circumstances noted above, the Company has requested
that its shares are suspended from trading on AIM with immediate effect.

Further announcements will be made as appropriate.

This announcement has been approved by Giulio Cesareo, Chief Executive, on
behalf of the Company.

 

For further information, please contact:

 

 Directa Plus plc                                       +39 02 36714458
 Giulio Cesareo, CEO

 Singer Capital Markets (Nominated Adviser and Broker)  +44 20 7496 3069
 Rick Thompson / Phil Davies/Carl Diebitsch

 Alma Strategic Communications (Financial PR Adviser)   +44 20 3405 0205
 Justine James / Hannah Campbell / Rose Docherty        directaplus@almastrategic.com (mailto:directaplus@almastrategic.com)

 

Notes

¹ In Italy, statutory auditors form a mandatory corporate body for SpA
companies, responsible for supervising compliance with the law and proper
management, rather than auditing financial statements which lies with
independent external auditors. They are elected for three years, must be
registered in the Ministerial Register, and act with professional
independence.

 

 

 

About Directa Plus

Directa Plus (www.directa-plus.com (http://www.directa-plus.com/) ) is one of
the largest producers and suppliers of graphene-based products for use in
consumer and industrial markets. The Company's graphene manufacturing
capability uses proprietary patented technology based on a plasma super
expansion process. Starting from natural graphite, each step of Directa
Plus's production process - expansion, exfoliation and drying - creates
graphene-based materials and hybrid graphene materials ready for a variety of
uses and available in various forms such as powder, liquid and past.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product,
without unwanted by-products. Directa Plus's products are made of hybrid
graphene materials and graphene nano-platelets. The products (marketed as
G+®) have multiple applications due to its properties. These G+® products
can be categorised into various families, with different products being
suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomaz (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May
2016. The Company holds the Green Economy Mark from London Stock
Exchange which recognises companies that contribute to the global green
economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURUOONRNUUSARR



            Copyright 2019 Regulatory News Service, all rights reserved